Suvorexant: a promising, novel treatment for insomnia
Joyce K Lee-Iannotti,1 James M Parish2 1Division of Neurology, Sleep Disorders Center, Banner University Medical Center, Phoenix, AZ, USA; 2Division of Pulmonary Medicine, Center for Sleep Medicine, Mayo Clinic, Phoenix, AZ, USA Abstract: Suvorexant a novel, orexin receptor antagonist was recently...
Enregistré dans:
Auteurs principaux: | Lee-Iannotti JK, Parish JM |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f0c588f9105d42cc928f5aef83bf3bb5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
par: Norman JL, et autres
Publié: (2016) -
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
par: Rosenberg R, et autres
Publié: (2021) -
Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients
par: Firouzabadi N, et autres
Publié: (2020) -
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
par: Chow M, et autres
Publié: (2016) -
Brief behavioral treatment for patients with treatment-resistant insomnia
par: Wang J, et autres
Publié: (2016)